The estimated Net Worth of Barbara A Wood is at least $795 Mille dollars as of 5 December 2022. Ms. Wood owns over 2,153 units of SELLAS Life Sciences Inc stock worth over $74,374 and over the last 8 years she sold SLS stock worth over $14,540. In addition, she makes $705,672 as Executive Vice President, General Counsel e Corporate Secretary at SELLAS Life Sciences Inc.
Barbara has made over 3 trades of the SELLAS Life Sciences Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she sold 2,153 units of SLS stock worth $5,576 on 5 December 2022.
The largest trade she's ever made was selling 2,153 units of SELLAS Life Sciences Inc stock on 5 December 2022 worth over $5,576. On average, Barbara trades about 197 units every 114 days since 2016. As of 5 December 2022 she still owns at least 56,344 units of SELLAS Life Sciences Inc stock.
You can see the complete history of Ms. Wood stock trades at the bottom of the page.
Barbara A. Wood Esq., J.D. serves as Executive Vice President, General Counsel, Corporate Secretary of the Company. Ms. Wood has served as the Company’s Executive Vice President, General Counsel and Corporate Secretary since March 2018. Prior to joining the Company, Ms. Wood served as Senior Vice President, General Counsel and Corporate Secretary at IVERIC bio, Inc. (formerly known as Ophthotech Corporation) from November 2013 to February 2018. From January 2011 to November 2013, Ms. Wood practiced law at Wood Legal. From April 2001 to December 2010 Ms. Wood served in varying roles at OSI Pharmaceuticals, Inc., most recently as Senior Vice President, General Counsel and Corporate Secretary. Before joining OSI, Ms. Wood was a partner at the New York law firm of Squadron, Ellenoff, Plesent & Sheinfeld (now part of Hogan Lovells), focusing on mergers and acquisitions, biotechnology, licensing, securities and venture capital matters Ms. Wood received her B.A. in Economics and Classics, magna cum laude, from Connecticut College and her J.D. from Columbia Law School where she was a Harlan Fiske Stone Scholar.
As the Executive Vice President, General Counsel e Corporate Secretary of SELLAS Life Sciences Inc, the total compensation of Barbara Wood at SELLAS Life Sciences Inc is $705,672. There are 2 executives at SELLAS Life Sciences Inc getting paid more, with Angelos Stergiou having the highest compensation of $1,426,610.
Barbara Wood is 58, she's been the Executive Vice President, General Counsel e Corporate Secretary of SELLAS Life Sciences Inc since 2018. There are 4 older and 9 younger executives at SELLAS Life Sciences Inc. The oldest executive at SELLAS Life Sciences Group Inc is David Scheinberg, 64, who is the Director.
Barbara's mailing address filed with the SEC is C/O SELLAS LIFE SCIENCES GROUP, INC.,, 7 TIMES SQUARE, SUITE 2503, NEW YORK,, NY, 10036.
Over the last 7 years, insiders at SELLAS Life Sciences Inc have traded over $74,616 worth of SELLAS Life Sciences Inc stock. The most active insiders traders include John Varian, Jane Wasman e David A Scheinberg. On average, SELLAS Life Sciences Inc executives and independent directors trade stock every 205 days with the average trade being worth of $6,842. The most recent stock trade was executed by Angelos M. Stergiou on 5 December 2022, trading 6,494 units of SLS stock currently worth $16,949.
σellas life sciences is a healthcare-oriented global group of companies with a unique and innovative vision, which is ambitious, yet clear: to practice the medicine of tomorrow, today. in other words, we incorporate innovation throughout all our activities aiming at breakthroughs that will have a significant impact on the thinking and practicing of healthcare worldwide. our international team of acknowledged scientists, doctors and health professionals along with a seasoned and highly experienced pharmaceutical executive management form the core of σellas. we strive to improve patients' quality of life through developing and commercializing cutting-edge drugs, medical devices and innovative therapies.
SELLAS Life Sciences Inc executives and other stock owners filed with the SEC include: